p., purple line, n = 6), Lenalidomide (15 mg/kg i. p., blue line, n = 6), or BPTES/ Lenalidomide (red line, n = 6) for 10 days, and tumor volume was calculated. Data are represented as the folds change in tumor volume (T0) ± SEM of 6 mice per group. The difference in RTV is highly significant as labeled. (B) Western-blot of GLS1 for cells isolated from vehicle or Lenalidomide treated tumors. Tumor numbers are indicated. GAPDH served as the western-blot loading control. (C) The concentration of α-KG in treated tumors (n = 3, in each groups) was measured with MS, and data were presented with the relative to that in vehicle treated tumors. Statistically significant differences are labeled as indicated. Significantly upregulated changed gene set list from GSEA analysis of whole gene expression of MK-Gls1R2s-transduced PCT cells compared to MK-LAZR-transduced PCT cells in Molecular Signatures Database.
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